159 related articles for article (PubMed ID: 8718562)
1. Retention of cytokine-inducing substances inside high-flux dialyzers.
Lufft V; Mahiout A; Shaldon S; Koch KM; Schindler R
Blood Purif; 1996; 14(1):26-34. PubMed ID: 8718562
[TBL] [Abstract][Full Text] [Related]
2. Transfer of cytokine-inducing bacterial products across hemodialyzer membranes in the presence of plasma or whole blood.
Pereira BJ; Sundaram S; Barrett TW; Butt NK; Porat R; King AJ; Dinarello CA
Clin Nephrol; 1996 Dec; 46(6):394-401. PubMed ID: 8982556
[TBL] [Abstract][Full Text] [Related]
3. New polyether sulfone dialyzers attenuate passage of cytokine-inducing substances from pseudomonas aeruginosa contaminated dialysate.
Jaber BL; Gonski JA; Cendoroglo M; Balakrishnan VS; Razeghi P; Dinarello CA; Pereira BJ
Blood Purif; 1998; 16(4):210-9. PubMed ID: 9736790
[TBL] [Abstract][Full Text] [Related]
4. Transmembrane passage of cytokine-inducing bacterial products across new and reprocessed polysulfone dialyzers.
Sundaram S; Barrett TW; Meyer KB; Perrella C; Neto MC; King AJ; Pereira BJ
J Am Soc Nephrol; 1996 Oct; 7(10):2183-91. PubMed ID: 8915979
[TBL] [Abstract][Full Text] [Related]
5. Cytokine production during in vitro hemodialysis with new and formaldehyde- or renalin-reprocessed cellulose dialyzers.
Pereira BJ; Snodgrass B; Barber G; Perella C; Chopra S; King AJ
J Am Soc Nephrol; 1995 Oct; 6(4):1304-8. PubMed ID: 8589302
[TBL] [Abstract][Full Text] [Related]
6. Pyrogen retention by the Asahi APS-650 polysulfone dialyzer during in vitro dialysis with whole human donor blood.
Linnenweber S; Lonnemann G
ASAIO J; 2000; 46(4):444-7. PubMed ID: 10926143
[TBL] [Abstract][Full Text] [Related]
7. Induction of interleukin-1 and interleukin-1 receptor antagonist during contaminated in-vitro dialysis with whole blood.
Schindler R; Krautzig S; Lufft V; Lonnemann G; Mahiout A; Marra MN; Shaldon S; Koch KM
Nephrol Dial Transplant; 1996 Jan; 11(1):101-8. PubMed ID: 8649615
[TBL] [Abstract][Full Text] [Related]
8. Pyrogen retention by highly permeable synthetic membranes during in vitro dialysis.
Lonnemann G; Sereni L; Lemke HD; Tetta C
Artif Organs; 2001 Dec; 25(12):951-60. PubMed ID: 11843762
[TBL] [Abstract][Full Text] [Related]
9. Diffusive and convective transfer of cytokine-inducing bacterial products across hemodialysis membranes.
Pereira BJ; Snodgrass BR; Hogan PJ; King AJ
Kidney Int; 1995 Feb; 47(2):603-10. PubMed ID: 7723247
[TBL] [Abstract][Full Text] [Related]
10. Differences in the permeability of high-flux dialyzer membranes for bacterial pyrogens.
Schindler R; Christ-Kohlrausch F; Frei U; Shaldon S
Clin Nephrol; 2003 Jun; 59(6):447-54. PubMed ID: 12834177
[TBL] [Abstract][Full Text] [Related]
11. Blood components influence cytokine induction by bacterial substances.
Schindler R; Eichert F; Lepenies J; Frei U
Blood Purif; 2001; 19(4):380-7. PubMed ID: 11574734
[TBL] [Abstract][Full Text] [Related]
12. National Kidney Foundation report on dialyzer reuse. Task Force on Reuse of Dialyzers, Council on Dialysis, National Kidney Foundation.
Am J Kidney Dis; 1997 Dec; 30(6):859-71. PubMed ID: 9398135
[TBL] [Abstract][Full Text] [Related]
13. Permeability of dialyzer membranes to TNF alpha-inducing substances derived from water bacteria.
Lonnemann G; Behme TC; Lenzner B; Floege J; Schulze M; Colton CK; Koch KM; Shaldon S
Kidney Int; 1992 Jul; 42(1):61-8. PubMed ID: 1635355
[TBL] [Abstract][Full Text] [Related]
14. The role of plasma coating on the permeation of cytokine-inducing substances through dialyser membranes.
Lonnemann G; Schindler R; Lufft V; Mahiout A; Shaldon S; Koch KM
Nephrol Dial Transplant; 1995; 10(2):207-11. PubMed ID: 7753454
[TBL] [Abstract][Full Text] [Related]
15. Reprocessed (high-flux) Polyflux dialyzers resist trans-membrane endotoxin passage and attenuate inflammatory markers.
Teehan GS; Guo D; Perianayagam MC; Balakrishnan VS; Pereira BJ; Jaber BL
Blood Purif; 2004; 22(4):329-37. PubMed ID: 15240988
[TBL] [Abstract][Full Text] [Related]
16. Do cytokine-inducing substances penetrate through dialysis membranes and stimulate monocytes?
Kumano K; Yokota S; Nanbu M; Sakai T
Kidney Int Suppl; 1993 Jun; 41():S205-8. PubMed ID: 8320922
[TBL] [Abstract][Full Text] [Related]
17. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
[TBL] [Abstract][Full Text] [Related]
18. Ultrafiltration and endotoxin removal from dialysis fluids.
Di Felice A; Cappelli G; Facchini F; Tetta C; Cornia F; Aimo G; Lusvarghi E
Kidney Int Suppl; 1993 Jun; 41():S201-4. PubMed ID: 8320921
[TBL] [Abstract][Full Text] [Related]
19. Dialyzer reuse--part II: advantages and disadvantages.
Twardowski ZJ
Semin Dial; 2006; 19(3):217-26. PubMed ID: 16689973
[TBL] [Abstract][Full Text] [Related]
20. Detection of peptidoglycan and endotoxin in dialysate, using silkworm larvae plasma and limulus amebocyte lysate methods.
Tsuchida K; Takemoto Y; Yamagami S; Edney H; Niwa M; Tsuchiya M; Kishimoto T; Shaldon S
Nephron; 1997; 75(4):438-43. PubMed ID: 9127331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
